Acta E transforms from Structure Reports Online to Crystallographic Communications

Notes for authors

Crystal structures of (μ₂-η²,η²-4-hydroxybut-2-yn-1-yl 2-bromo-2-methylpropanoate-κ⁴C²,C³:C²,C³)bis­[tri­carbonylcobalt(II)](Co—Co) and [μ₂-η²,η²-but-2-yne-1,4-diyl bis­(2-bromo-2-methyl­propanoate)-κ⁴C²,C³:C²,C³]bis­[tri­carbonylcobalt(II)](Co—Co)

The structures of two alkyne-hexacarbonyl-dicobalt complexes are reported, each with potential ATRP initiator substrates as substituents on the alkynes. The complexes each form tetrahedral C₂Co₂ cluster cores with classical sawhorse conformations, while a feature of the crystal packing is the formation of inversion dimers for both molecules.

Crystal structure of Pb₃(IO₄(OH)₂)₂

The basic building units of the hydrous periodate Pb₃(IO₄(OH)₂)₂ are three Pb²⁺ cations and two IO₄(OH)₂³⁻ anions. The octa­hedral anions are arranged in a distorted hexa­gonal rod packing, with the cations (each with a coordination number of eight) located in between.

Crystal structures of N-(pyridin-2-ylmeth­yl)pyrazine-2-carboxamide (monoclinic polymorph) and N-(pyridin-4-ylmeth­yl)pyrazine-2-carboxamide

The title molecules, HL1 and HL2, differ in their conformation with the pyridine ring being inclined to the pyrazine ring by 61.34 (6) and 84.33 (12)°, respectively. The crystal packing is also slightly different, with molecules of HL1 linked by pairs of N—H⋯N hydrogen bonds, forming inversion dimers, while for HL2 molecules are linked by N—H⋯N and C—H⋯N hydrogen bonds, forming chains along [010].

Crystal structure of poly[[(acetato-κO){μ₃-N-[(pyridin-4-yl)meth­yl]pyrazine-2-carboxamidato-κ⁴N:N¹,N²:N⁴]copper(II)] dihydrate]: a metal–organic framework (MOF)

The title compound, a hydrated copper acetate complex of the ligand N-[(pyridin-4-yl)methyl]pyrazine-2-carboxamide, has a metal-organic framework (MOF) structure with a 10 (3) network topology. The water molecules are located in the cavities of the framework and linked to it by O—H⋯O hydrogen bonds.

Crystal structure of ammonium divanadium(IV,V) tellurium(IV) hepta­oxide

In the title layered, mixed-valence ammonium vanadium tellurite, the V^V atom are tetrahedrally coordinated and the V^IV atoms adopt distorted octahedral coordination geometries. The presumed Te^IV lone pairs of electrons are directed inwards into lacunae in the double polyhedral layers.

Crystal structures of 1,4-di­aza­bicyclo­[2.2.2]octan-1-ium 4-nitro­benzoate dihydrate and 1,4-di­aza­bicyclo­[2.2.2]octane-1,4-diium bis­(4-nitro­benzoate): the influence of solvent upon the stoichiometry of the formed salt

Solvent-dependent outcomes are noted in co-crystallization experiments between DABCO and 4-nitrobenzoic acid with mono- and diprotonated forms of DABCO are isolated.

Crystal structure of chlorido­(piperidine-κN)(quinoline-2-carboxyl­ato-κ²N,O)platinum(II)

The platinum(II) complex with notable antitumor activity shows a slightly distorted square-planar coordination and intramolecular C—H⋯Cl and intermolecular N—H⋯Cl and C—H⋯O hydrogen bonds.

Crystal structures of 2,5-di­azido-1,4-phenyl­ene di­acetate and 2,5-di­azido-1,4-phenyl­ene dibutyrate

2,5-Di­azido-1,4-phenyl­ene di­acetate and dibutyrate are the first structurally characterized representatives with a trans-di­azido­phenyl­ene entity. Both mol­ecules possess inversion symmetry; however, the compounds crystallize in different crystal systems (triclinic versus monoclinic).

Tetra­ammineplatinum(II) dichloride ammonia tetra­solvate

Tetra­amminepalladium(II) dichloride ammonia tetra­solvate

Dimanganese(II) hydroxide vanadate, Mn₂(OH)[VO₄]

Thortveitite-type Tm₂Si₂O₇

Non-centrosymmetric Rb₂Mn₂(MoO₄)₃

β-K₃Fe(MoO₄)₂Mo₂O₇

The solid solution K_3.84Ni_0.78Fe_3.19(PO₄)₅

Rietveld refinement of the langbeinite-type mixed-metal phosphate K₂Ni_0.5Zr_1.5(PO₄)₃

μ₂-Acetato-κ²O:O′-(4,4′-bi­pyridyl-κN)tris­(di­ethyl di­thio­phosphato-κ²S,S′)-μ₃-sulfido-tri-μ₂-sulfido-trimolybdenum(IV) di­ethyl ether monosolvate

Octa-μ₃-selenido-penta­kis­(tri­ethyl­phos­phane-κP)(tri­methyl­aceto­nitrile-κN)-octa­hedro-hexa­rhenium(III) bis­(hexa­fluorido­anti­monate) tri­methyl­aceto­nitrile monosolvate

catena-Poly[[bis­(dicyanamido-κN¹)cobalt(II)]bis­{μ-1,2-bis­[(1,2,4-triazol-1-yl)meth­yl]benzene-κ²N⁴:N^4′}]

(η⁴-Cyclo­octa­tetra­ene)(η⁸-cyclo­octa­tetra­ene)iodido­tantalum(V)

Poly[[tris­(μ₂-acetato-κ²O:O′)(4-chloro­benzene-1,2-di­amine-κN)(μ₃-hydroxido)dizinc] ethanol monosolvate]

Bis{bis­[1-meth­oxy-2-(2-meth­oxy­eth­oxy)ethane-κ³O,O′,O′′]sodium} 1,1,2,2-tetra­phenyl­ethane-1,2-diide

(5-n-Butyl-10,20-diiso­butyl­porphyrin­ato)nickel(II)

trans-Bis[2,5-bis­(pyridin-2-yl)-1,3,4-thia­diazole-κ²N²,N³]bis­(methanol-κO)iron(II) bis­(perchlorate)

A cyclo­octa­trienone complex of diiron hexa­carbon­yl

(η⁶-Benzene)­dichlorido­(chloro­dicyclo­hexyl­phosphane-κP)ruthenium(II) chloro­form monosolvate

Di­chlorido­(5,10,15,20-tetra­phenyl­porphyrinato-κ⁴N)anti­mony(V) hexa­chlorido­anti­monate(V)

Redetermination of di­aqua­tris­(4-oxo­pent-2-en-2-olato-κ²O,O′)lanthanum(III)

(18-Crown-6)potassium(I) di­phenyl­stibate(−1)

Poly[guanidinium [tri-μ-formato-κ⁶O:O′-formato-κ²O,O′-yttrium(III)]]

Bis(4-amino­pyridinium) dichromate(VI)

Poly[tris­(μ-4,4′-bi­pyridine-κ²N:N′)bis­(di­methyl sulfoxide-κO)tetra­kis­(thiocyanato-κN)dicobalt(II)]

catena-Poly[[(pyrazine-2-carboxamide-κN⁴)copper(I)]-μ₃-iodido]

Bis(1,3-thia­zol-2-aminium) hexa­chlorido­stannate(IV)

Poly[[(μ₄-benzene-1,3,5-tri­carboxyl­ato-κ⁴O¹:O^1′:O²:O³)bis­(2,2-bi­pyridine-κ²N,N′)(μ₂-hydroxido)dicopper(II)] trihydrate]

(η⁶-Benzene)(carbonato-κ²O,O′)[di­cyclohex­yl(naphthalen-1-ylmeth­yl)phosphane-κP]ruthenium(II) chloro­form tris­olvate

Bis{N-[2-hy­droxy-1,1-bis­(hy­droxy­methyl)eth­yl]glycinato-κ³O,N,O′}iron(II)

catena-Poly[[trans-bis­(1,3-benzo­thia­zole-κN)manganese(II)]-di-μ-chlorido]

Hexa-μ₂-chlorido-μ₄-oxido-tetra­kis[(morpholine-κN)copper(II)] methanol disolvate

fac-[1,2-Bis(pyridin-4-yl)ethane-κN]tricarbon­yl(1,10-phenanthroline-κ²N,N′)rhenium(I) hexa­fluorido­phosphate aceto­nitrile monosolvate

Bis[trans-di­fluorido­tetra­kis­(pyridine-κN)chromium(III)] sodium tetra­chlorido­zincate perchlorate from synchrotron data

(N-Phenyl­thio­urea-κS)bis­(tri­phenylphosphane-κP)silver(I) nitrate

{4-Amino-N′-[(2-oxidonaphthalen-1-yl)methyl­idene]benzohydrazidato}di­methyl­tin(IV)

(Z)-3-[(2-Amino­benz­yl)amino]-1-phenyl­but-2-en-1-one

8-Chloro-4-oxo-4H-chromene-3-carbaldehyde

6-Iodo-4-oxo-4H-chromene-3-carbaldehyde

Ethyl 2-[({[4-amino-5-cyano-6-(methyl­sulfan­yl)pyridin-2-yl]carbamo­yl}meth­yl)sulfan­yl]acetate monohydrate

Bis(2-amino-4-methyl-6-oxo-3,6-di­hydro­pyrimidin-1-ium) sulfate monohydrate

2,3,5,6-Tetra­fluoro-1,4-bis­({[(thio­phen-2-yl)methyl­idene]amino}­meth­yl)benzene

Ethyl (2Z)-3-hy­droxy-3-(4-nitro­phen­yl)prop-2-enoate

(E)-3-Chloro-N′-(2-fluoro­benzyl­idene)thio­phene-2-carbohydrazide

4-[(4-Acetyl­phen­yl)amino]-2-methyl­idene-4-oxo­butanoic acid

Vinclozolin: 3-(3,5-di­chloro­phen­yl)-5-ethenyl-5-methyl-1,3-oxazolidine-2,4-dione

Methyl 5-methyl-1-(1H-pyrazol-3-yl)-1H-1,2,3-triazole-4-carboxyl­ate

4-Cyano-1-methyl­pyridinium perchlor­ate

Corymbolone

5′-([1,1′-Biphen­yl]-4-yl)-1′,1′′,3′′-tri­methyl­dispiro[indane-2,2′-pyrrolidine-4′,5′′-[1,3]diazin­ane]-1,3,2′′,4′′,6′′-penta­one

2-[4-(Tri­fluoro­meth­yl)phen­yl]-1H-benzimidazole

1-{3-(4-Chloro­phen­yl)-5-[4-(propan-2-yl)phen­yl]-4,5-di­hydro-1H-pyrazol-1-yl}butan-1-one

1-{3-(4-Chloro­phen­yl)-5-[4-(propan-2-yl)phen­yl]-4,5-di­hydro-1H-pyrazol-1-yl}propan-1-one

Bis(2-bromo­benz­yl) ether

3-(Adamantan-1-yl)-4-benzyl-1H-1,2,4-triazole-5(4H)-thione

6-[(2-Methyl­phen­yl)sulfan­yl]-5-propyl­pyrimidine-2,4(1H,3H)-dione

3-Bromo-N-(3,5-di-tert-butyl­phen­yl)propanamide

N-[(1-Benzoyl­piperidin-4-yl)meth­yl]benzamide

1-(Morpholin-4-yl)-4-(2-nitro­phen­yl)spiro­[azetidine-3,9′-xanthen]-2-one

8-Fluoro-4-oxo-4H-chromene-3-carbalde­hyde

2-[(E)-1,1-Dioxo-2-(2,4,5-tri­fluoro­benz­yl)-3,4-di­hydro-2H-1,2-benzo­thia­zin-4-yl­idene]acetic acid

2-[(3S,3aS,5R,8S,8aS)-3,8-Di­methyl­hexa­hydro-1H,4H-3a,8a-ep­oxy­azulen-5-yl]propan-2-ol

2-[(Pyridin-2-yl)amino]­pyridinium 2,4,6-tri­nitro­phenolate

4-[(4-Bromo­phenyl)amino]-2-methyl­idene-4-oxo­butanoic acid

1-{3-(4-Chloro­phen­yl)-5-[4-(propan-2-yl)phen­yl]-4,5-di­hydro-1H-pyrazol-1-yl}ethanone

N-Methyl-N-nitroso-p-toluene­sulfon­amide

(tert-But­yl)(2-hy­droxy­eth­yl)ammonium chloride

(E)-4-Meth­oxy-N′-[(6-methyl-4-oxo-4H-chromen-3-yl)methyl­idene]benzo­hydrazide monohydrate

2-[2,6-Bis(propan-2-yl)phen­yl]-1,3-di­cyclo­hexyl­guanidine

(R,S)-2′-Amino-6′-methyl-2,5′,5′-trioxo-6′H-spiro­[indoline-3,4′-pyrano[3,2-c][2,1]benzo­thia­zine]-3′-carbo­nitrile di­methyl­formamide monosolvate

2,3-Di­methyl­quinazolin-4(3H)-one

2-[5-(2-Methyl­phen­yl)-3-(2-methyl­styryl)-4,5-di­hydro-1H-pyrazol-1-yl]-6-(thio­phen-2-yl)-4-(tri­fluoro­meth­yl)pyrimidine chloro­form monosolvate

Di­ethyl 4-(bi­phenyl-4-yl)-2,6-di­methyl-1,4-di­hydro­pyridine-3,5-di­carboxyl­ate

(E)-N′-(3,4-Di­meth­oxy­benzyl­idene)nicotinohydrazide monohydrate

Ethyl 6-amino-5-cyano-4-phenyl-2,4-di­hydro­pyrano[2,3-c]pyrazole-3-carboxyl­ate di­methyl sulfoxide monosolvate

6-Bromo-N-(6-bromo­pyridin-2-yl)-N-[4-(2,3-di­hydro­thieno[3,4-b][1,4]dioxin-5-yl)phen­yl]pyridin-2-amine

2-{4-[Bis(4-bromo­phen­yl)amino]­benzyl­idene}malono­nitrile

(E)-4-{[(Morpholin-4-yl)imino]­meth­yl}benzo­nitrile

N-Methyl-2-(1-methyl-3-phenyl­prop-2-en-1-yl­idene)hydrazinecarbo­thio­amide

4-Chloro-3-ethyl­phenol

Ethyl 2,6-bis­(4-chloro­phen­yl)-1-iso­cyano-4-oxo­cyclo­hexa­necarboxyl­ate

4-(2,3-Di­hydro­thieno[3,4-b][1,4]dioxin-5-yl)aniline

6-Chloro-7-methyl-4-oxo-4H-chromene-3-carbaldehyde

3,4,6-Tri­amino-N-phenyl­thieno[2,3-b]pyridine-2-carboxamide

N¹-[(1H-Imidazol-2-yl)methyl­idene]-N⁴-phenyl­benzene-1,4-di­amine

Diafenthiuron: 1-tert-butyl-3-(2,6-diiso­propyl-4-phen­oxy­phen­yl)thio­urea

5-Bromo-3-ethyl­sulfinyl-2-(4-methyl­phen­yl)-1-benzo­furan

(E)-1-([1,1′-Biphen­yl]-4-yl)-3-(2-methyl­phen­yl)prop-2-en-1-one

3-Cyano-N-methylpyridinium perchlorate

2,6-Di­amino-4-(4-chloro­phen­yl)-1-methyl-1,4-di­hydro­pyridine-3,5-dicarbo­nitrile

[4-(All­yloxy)phen­yl](phen­yl)methanone

5-Amino-5′-bromo-6-(4-methyl­benzo­yl)-8-nitro-2,3-di­hydro-1H-spiro­[imidazo[1,2-a]pyridine-7,3′-indolin]-2′-one including an unknown solvate

2-Bromo-1-[1-(4-bromo­phen­yl)-5-methyl-1H-1,2,3-triazol-4-yl]ethanone

3-Oxo-N′,2-di­phenyl-2,3-di­hydro-1H-pyrazole-4-carbohydrazide

2′,7′-Di­bromo­spiro­[cyclo­propane-1,9′-fluorene]

2-Bromo-5-tert-butyl-N-methyl-N-[2-(methyl­amino)­phen­yl]-3-(1-methyl-1H-benzimidazol-2-yl)benzamide

(4R)-3-Hy­droxy-7-iso­propyl-4-methyl-5,6-di­hydro­benzo­furan-2(4H)-one

6-Chloro-7-fluoro-4-oxo-4H-chromene-3-carbaldehyde

2,2,6,6-Tetra­bromo-3,4,4,5-tetra­meth­oxy­cyclo­hexa­none

1-[(Cyclo­hexyl­idene)amino]-3-(prop-2-en-1-yl)thio­urea

5-Fluoro-2-(2-fluoro­phen­yl)-3-methyl­sulfinyl-1-benzo­furan

3-(4-Fluoro­phenyl­sulfin­yl)-2,4,5,6-tetra­methyl-1-benzo­furan

N-(2-Allyl-4-eth­oxy-2H-indazol-5-yl)-4-methyl­benzene­sulfonamide. Corrigendum

Corrigendum to Acta Cryst. (2014), E70, o624.